VF
BHVN

Virtu Financial’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Virtu Financial’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-161,174
Closed -$24.4M – 2632
2022
Q3 		$24.4M Buy
161,174
+159,754
+11,250% +$23.7M 2.23% 4
2022
Q2 		$207K Buy
+1,420
New +$181K 0.02% 753
2021
Q3 		– Sell
-4,808
Closed -$467K – 2383
2021
Q2 		$467K Buy
+4,808
New +$390K 0.05% 505
2020
Q3 		– Sell
-12,573
Closed -$919K – 1834
2020
Q2 		$919K Buy
+12,573
New +$669K 0.11% 206
2019
Q4 		– Sell
-6,419
Closed -$268K – 2099
2019
Q3 		$268K Buy
+6,419
New +$271K 0.02% 815

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

Virtu Financial's BHVN Position: Q4 2022 in Review

Virtu Financial sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 161,174 shares — an estimated $24.4M sold.

Virtu Financial first reported a position in BHVN in Q3 2019 and held it in 5 quarters. The position peaked at $24.4M in Q3 2022. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • Virtu Financial reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • Virtu Financial sold 161,174 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $24.4M.
  • Virtu Financial first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q3 2019 and held it in 5 quarters.
  • Virtu Financial's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $24.4M in Q3 2022.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on Virtu Financial's 13F filing for Q4 2022, filed 15 Feb 2023.